-
Neurology
Advances in cancer chemotherapy have brought longer and more active lives for many patients but have left some with a mysterious and troubling burden.
Journal of the American Medical Association - Thu, 5 June 2008
http://jama.ama-assn.org/
-
General medicine
The road to death or differentiation follows a similar course in embryonic stem cells: caspases, known as 'killer enzymes,' that are activated during programmed cell death, are also active in the initial phases of cell differentiation.
Baylor College of Medicine - Thu, 5 June 2008
http://www.bcm.edu
-
Psychiatry
The Conference will be broadcasted live on the Public Health Portal. See the programme and join the event online.
Health-EU - Thu, 5 June 2008
http://ec.europa.eu/health-eu/index_en.htm
-
Immunology
European Commission organised a workshop to exchange ideas with the vaccination policy makers of the EU Member States on measles and rubella elimination, public perception of vaccines, seasonal flu vaccination and HPV vaccination.
Health-EU - Thu, 5 June 2008
http://ec.europa.eu/health-eu/index_en.htm
-
Allergology
New research findings may be the cure for cancer patients who have developed allergies to chemotherapy treatment.
American Academy of Allergy, Asthma and Immunology - Thu, 5 June 2008
http://www.aaaai.org
-
Psychiatry
Transference interpretation has remained a core ingredient in the psychodynamic tradition, despite limited empirical evidence for its effectiveness. In this study, the authors examined long-term effects of transference interpretations.
American Journal of Psychiatry - Thu, 5 June 2008
http://ajp.psychiatryonline.org/
-
Infectious Diseases
Nearly 3 million people are now receiving anti-retroviral therapy in low- and middle-income countries, according to a new report jointly launched today by WHO, UNAIDS and UNICEF.
World Health Organization - Wed, 4 June 2008
http://www.who.int
-
Pediatrics
Sudden unexplained death in infancy (SUDIs) is one of the most common presentations of post-neonatal infant death in the UK with many theories existing about its cause.
The Lancet - Wed, 4 June 2008
http://www.thelancet.com
-
Neurology
The ketogenic diet, which is high in fat and low in carbohydrate and protein, has been used sporadically since the 1920s to treat refractory epilepsy, despite its mechanism of action being unknown.
The Lancet Neurology - Wed, 4 June 2008
http://www.thelancet.com/journals/laneur
-
Neurology
Up to a third of all cases of epilepsy are refractory to existing therapies and require surgery or experimental treatments.
The Lancet Neurology - Wed, 4 June 2008
http://www.thelancet.com/journals/laneur